Sandra Levy
ARTICLES BY THIS AUTHOR
- 7/27/2020
Hy-Vee pharmacies to offer drive-up flu vaccines
Hy-Vee announced plans to offer in-store and drive-up flu vaccines beginning Aug 17. - 7/27/2020
Mayne Pharma obtains FDA blessing for chlorzoxazone
Chlorzoxazone had a market value of approximately $25 million for the 12 months ended May 31, according to IQVIA. - 7/27/2020
PTCB grants help pharmacy associations with tech leadership training, opioid education
Mississippi, Ohio, Oregon and Wisconsin associations are receiving Pharmacy Technician Certification Board Project grants. - 7/26/2020
Trump issues executive orders aimed at lowering drug prices
President Donald Trump issued four executive orders Friday, largely focused on bringing down drug costs, which split the industry in terms of reactions. - 7/26/2020
Cognivue taps Fred Ma as chief medical officer, senior vice president
Cognivue's new chief medical officer and senior vice president, Fred Ma, has four decades of experience spanning medical device and pharmaceutical development and commercialization. - 7/26/2020
Dr. Reddy's gets FDA nod for Xeglyze
Dr. Reddy's Xeglyze is indicated for patients with a head lice infestation. - 7/26/2020
ScripTalk survey: Talking labels boost med safety for visually impaired patients
A new survey shows that after using ScripTalk, no participating patients experienced a medication error related to mixing up medications or taking the wrong medication/dosage. - 7/23/2020
NACDS urges pharmacy policies to remain amid COVID-19
The president and CEO of the National Association of Chain Drug Stores, Steve Anderson, penned a letter encouraging states to maintain policies that help pharmacies meet patients’ needs during the COVID-19 pandemic and in anticipation of flu season. - 7/23/2020
NACDS Foundation selects 2020-2021 faculty scholars
The National Association of Chain Drug Stores Foundation has chosen five faculty members from pharmacy schools and colleges nationwide to participate in the 2020-2021 Faculty Scholars Program. - 7/23/2020
Hikma releases dacarbazine
Dacarbazine for injection had a market value of roughly $2 million for the 12 months ended May 2020, according to IQVIA.
